Inflammation  >>  fuzheng Huayu  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
fuzheng Huayu / Shanghai Sundise
NCT00854087: Assess the Antifibrotic Activity of Fuzheng Huayu in Chronic Hepatitis C Patients With Hepatic Fibrosis

Completed
2
118
US
Fuzheng Huayu, Gan Ping, 319 Recipe, FZHY, Placebo
Tarek Hassanein, Shanghai Sundise Traditional Chinese Medicine Co., Ltd.
Chronic Hepatitis C Infection
04/13
08/13
Fzhy-ncp-2, NCT04279197: Treatment of Pulmonary Fibrosis Due to COVID-19 With Fuzheng Huayu

Completed
2
142
RoW
Fuzheng Huayu Tablet, FZHY, Vitamin C tablets, VC, Placebo, respiratory function rehabilitation training
ShuGuang Hospital, Hubei Hospital of Traditional Chinese Medicine, Jingmen No.1 People's Hospital, Wuhan No.1 Hospital, Wuhan Third Hospital, Huangshi Hospital of Traditional Chinese Medicine
Pulmonary Fibrosis Due to COVID-19
03/21
03/21

Download Options